Engineering Fundamentals in Life Science

Session 282 - Gene Therapy and Delivery (II)
This session will be devoted to the development of improved methods of gene transfer using both viral and non-viral approaches. Topics of interest include, but not limited to design of novel formulations for improved gene delivery, determination of rate-limiting steps of gene transfer, targeting of gene transfer vectors, methods for production and purification of viral and non-viral vectors and gene transfer to stem cells for tissue engineering applications. This session has been very well attended in previous years.
Chair:Stelios T. Andreadis
CoChair:Joseph M. Le Doux
 Immunization Via Skin Using Vaccine-Coated Microneedles
Harvinder S. Gill, Jonas Soderholm, Ioanna Skountzou, Joshy Jacob, Richard Compans, Matti Sallberg, Mark R. Prausnitz
 Construction of Hybrid Viral/Synthetic Gene Delivery Nanovectors
Josh Ramsey, Halong Vu, Daniel W. Pack
 Using RNA Interference to Probe Mechanism: Dnase II Is Not Rate Limiting in Non-Viral Gene Transfer to Endothelium
Gregory A. Barker, Scott L. Diamond
 Egf Ligands Decrease Retroviral Gene Transfer through Protein Kinase C-Delta
Raghvendra Singh, Stelios T. Andreadis
 Break
 Expression-Targeted Gene Therapy for the Treatment of Transitional Cell Carcinoma
Xiujuan Zhang, Anthony J. Atala, W. T. Godbey
 Analysis of Retroviral Decay: Protein and RNA Stability
Monica Casali, Jonathan Goldwasser, Z. Larkin Kelley, Zaki Megeed, Martin L. Yarmush
 Engineering Outer Membrane Vesicles for Gene Delivery
David Chen, Jae-Young Kim, Anne Doody, Matthew Delisa, David Putnam

See more of Food, Pharmaceutical & Bioengineering Division